Kuang-Chih Hsiao, A. Ponsonby, S. Ashley, C. Lee, L. Jindal, M. Tang
{"title":"花生过敏儿童益生菌和花生口服免疫治疗后对花生的纵向抗体反应","authors":"Kuang-Chih Hsiao, A. Ponsonby, S. Ashley, C. Lee, L. Jindal, M. Tang","doi":"10.1111/cea.14146","DOIUrl":null,"url":null,"abstract":"Probiotic and Peanut Oral Immunotherapy (PPOIT) is effective at inducing sustained unresponsiveness (SU) at end‐of‐treatment and this effect persists up to 4 years post‐treatment, referred to as persistent SU. We sought to evaluate (i) how PPOIT altered peanut‐specific humoral immune indices, and (ii) how such longitudinal indices relate to persistent SU.","PeriodicalId":10148,"journal":{"name":"Clinical & Experimental Allergy","volume":"1 1","pages":"735 - 746"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy\",\"authors\":\"Kuang-Chih Hsiao, A. Ponsonby, S. Ashley, C. Lee, L. Jindal, M. Tang\",\"doi\":\"10.1111/cea.14146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Probiotic and Peanut Oral Immunotherapy (PPOIT) is effective at inducing sustained unresponsiveness (SU) at end‐of‐treatment and this effect persists up to 4 years post‐treatment, referred to as persistent SU. We sought to evaluate (i) how PPOIT altered peanut‐specific humoral immune indices, and (ii) how such longitudinal indices relate to persistent SU.\",\"PeriodicalId\":10148,\"journal\":{\"name\":\"Clinical & Experimental Allergy\",\"volume\":\"1 1\",\"pages\":\"735 - 746\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Experimental Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/cea.14146\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Experimental Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/cea.14146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy
Probiotic and Peanut Oral Immunotherapy (PPOIT) is effective at inducing sustained unresponsiveness (SU) at end‐of‐treatment and this effect persists up to 4 years post‐treatment, referred to as persistent SU. We sought to evaluate (i) how PPOIT altered peanut‐specific humoral immune indices, and (ii) how such longitudinal indices relate to persistent SU.